Drug shortage
Meperidine Hydrochloride Injection · Hospira, Inc., a Pfizer Company
FDA drug shortage · Current · updated Sep 9, 2026
Key facts
| Generic name | Meperidine Hydrochloride Injection |
|---|---|
| Company | Hospira, Inc., a Pfizer Company |
| Presentation | Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Discontinuation of the manufacture of the drug |
| Therapeutic category | Analgesia/Addiction |
| Package NDCs | 0409-1362-01 |
| First posted | May 30, 2025 |
| Last updated | Sep 9, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: